Essential Hypertension Is Associated With Decreased Insulin Clearance and Insulin Resistance

Hypertension

Volumn 29, Issue 1, 1997, Pages 111-114

  Lender, Dan ^a   Arauz Pacheco, Carlos ^a   Adams Huet, Beverley ^a   Raskin, Philip ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN INFUSION; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY CONSTITUTION; FEMALE; HUMANS; HYPERINSULINISM; HYPERTENSION; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; OBESITY; REGRESSION ANALYSIS;

EID: 0031054444     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.29.1.111     Document Type: Article

References (28)

1. Subcommittee of Definition and Prevalence of the 1984 Joint National Committee. Hypertension prevalence and the state of awareness, treatment and control in the United States. Subcommittee of Definition and Prevalence of the 1984 Joint National Committee. Hypertension. 1985;7:457-468.
2. McMahon S, Peto R, Cutler J, Collin R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease, part 1: prolonged differences in blood pressure: projective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
3. Welborn TA, Breckenridge A, Dollery CT. Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966;1:1336-1337.
4. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
5. Stout RW. Insulin and atheroma: 20-year perspective. Diabetes Care. 1990;13:631-654.
6. Reaven GM. Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease. Diabete Metab. 1991;17:78-86.
7. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
8. Fontbonne A, Charles MA, Thibult N, Richard JL, Claude JR, Warnet JM, Rosselin GE, Eschwege E. Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow up. Diabetologia. 1991;34:356-361.
9. Ronnemaa T, Laakso M, Pyorala K, Kallio V, Puukka P. High fasting insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb. 1991;11:80-90.
10. Haffner SM, Stern MP, Watanabe RM, Bergman RN. Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest. 1992;22:147-153.
11. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
12. Shen DC, Shieh SM, Fuh MM, Wu DA, Chen YD, Reaven GM. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab. 1988;66:580-583.
13. Marigliano A, Tedde R, Sechi LA, Pala A, Pisanu G, Pacifico A. Insulinemia and blood pressure: relationships in patients with primary and secondary hypertension and with and without glucose metabolism impairment. Am J Hypertens. 1990;3:521-526.
14. Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1989;2:419-423.
15. Falkner B, Hulman S, Tennenbaum J, Kushner H. Insulin resistance and hypertension in young black men. Hypertension. 1990;16:708-711.
16. Pollare T, Lithel H, Berne C. Insulin resistance is a characteristic feature of hypertension independent of obesity. Metabolism. 1990;39:167-174.
17. Salvatore T, Cozzolino D, Giunta R, Guigliano D, Torella R, D'Onofrio F. Decreased insulin clearance as a feature of essential hypertension. J Clin Endocrinol Metab. 1992;74:144-148.
18. Swislocki AL. Impaired insulin clearance in essential hypertension. J Hum Hypertens. 1994;8:185-190.
19. Sheu WH, Jeng CY, Shieh SM, Fuh MM. Hepatic insulin extraction and insulin clearance in patients with essential hypertension. Clin Exp Hypertens. 1984;16:691-707.
20. DeFronzo RA, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin resistance and secretion. Am J Physiol. 1979;237:E214-E223.
21. Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ. How to measure insulin clearance. Diabetes Metab Rev. 1984;10:119-150.
22. Sherwin RS, Kramer KJ, Tobin JD, Insel PA, Liljenquist JE, Berman M, Andres R. A model of the kinetics of insulin in man. J Clin Invest. 1974;53:1481-1492.
23. Ferrannini E, Cobelli C. The kinetics of insulin in man, II: role of the liver. Diabetes Metab Rev. 1987;3:365-397.
24. Bergman RN, Steil GM, Bradley DC, Watanabe RM. Modeling of insulin action in vivo. Annu Rev Physiol. 1992;54:861-883.
25. Chen IIH, Prewitt RL, Dowell RF. Microvascular rarefaction in spontaneously hypertensive rat cremaster muscle. Am J Physiol. 1981;241:H306-H310.
26. Greene AS, Tenetallo PJ, Lui J, Tonellato PJ, Lui J, Lombaard J, Cowley AW Jr. Microvascular rarefaction and tissue vascular resistance in hypertension. Am J Physiol. 1989;256:H126-H131.
27. Parving HP, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res. 1973;32:643-651.
28. Nijs HGT, Radder JK, Frolich M, Krans MJ. In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes. 1990;39:333-339.